Biosion, Inc.
PrivateLast Round
Series B
Dec 1, 2022
Total Funding Raised
$45.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biosion, Inc. operates in Healthcare & Life Sciences and is based in Newark, Delaware. Its latest recorded funding round was a Series B round in December 2022.
Biosion, Inc. is a clinical-stage biotechnology company that develops antibody-based therapies for immune and oncologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biosion, Inc. Comparables
Compare Biosion, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpimAb Biotherapeutics | 82% | |
| Belenos Biosciences Inc. | 78% | |
| Adimab | 78% |
For institutional investors. Book with your work email.
Biosion, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2022 | ||||
| Series B Extension | Dec 9, 2021 | ||||
| VC Round | Dec 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biosion, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | Series B Extension |
| GF Xinde Investment Management | Series B |
| Lapam Capital | VC Round |
| Chase Capital | Series B Extension |
| Oceanpine Healthcare Fund | VC Round |
| 建发新兴投资 | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 136% MoM, reaching 304.
- May 14, 2025
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
Biosion, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biosion, Inc.'s valuation, stock price, and market status.
Is Biosion, Inc. a public or private company?
Biosion, Inc. is a private company.
What is the current stock price of Biosion, Inc.?
Biosion, Inc. is a private company, so its shares have no public market price. Caplight tracks Biosion, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biosion, Inc. worth (valuation)?
Valuation information for Biosion, Inc. is not publicly available.
Can I buy Biosion, Inc. stock?
Biosion, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biosion, Inc.'s last funding round?
Biosion, Inc.'s most recent funding round was Series B on December 1, 2022.
Who are the main investors in Biosion, Inc.?
Key investors in Biosion, Inc. include Bencao Capital, GF Xinde Investment Management, Lapam Capital.
Will Biosion, Inc. IPO soon?
No public IPO plans have been announced for Biosion, Inc..
How can I track Biosion, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Biosion, Inc.'s shares on secondary markets.